Download this handbook to learn more about the capabilities of mass photometry for evaluating antibody aggregation and ...

Antibody discovery is a critical engine of modern drug development, powering therapies for cancer, autoimmune diseases, and infectious disorders. For decades, discovery relied on traditional ...

The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo. Deleting a single ...

AI tools expedite antibody probe development, allowing researchers to track activity inside living cells. Researchers at Colorado State University (CSU; CO, USA) have determined how to use artificial ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act as lightbulbs, enabling scientists to better see inside living cells to ...

Antibodies touch nearly every corner of healthcare. These carefully crafted proteins can target cancer cells, control autoimmune diseases, fight infections, and destroy the toxic proteins that drive ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection. Protein-based therapeutics have been ...

Korea’s Celltrion is continuing to think bigger than biosmilars, this time securing the option to use TriOar’s antibody platform in a deal potentially worth more than $350 million. Under today’s ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

The antibody drug market value is expected to reach $445 billion in the next five years, with over 160 antibodies currently licensed globally for a wide breadth of conditions, including cancer, ...